The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Vaccine Adjuvants-Global Market Insights and Sales Trends 2025
Synopsis
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The global Vaccine Adjuvants market size is expected to reach US$ 1569.9 million by 2029, growing at a CAGR of 9.0% from 2023 to 2029. The market is mainly driven by the significant applications of Vaccine Adjuvants in various end use industries. The expanding demands from the Human Vaccine and Veterinary Vaccine, are propelling Vaccine Adjuvants market. Aluminum Adjuvant, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Emulsions Adjuvant segment is estimated at % CAGR for the next seven-year period.
The top 5 global manufacturers of vaccine adjuvants are GSK, CSL Limited, Croda, SEPPIC, Novavax, which have a combined market share of about 55 percent. North America is the largest market, with a share about 38%, followed by Europe and Asia Pacific with the share about 27% and 22%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vaccine Adjuvants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vaccine Adjuvants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vaccine Adjuvants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vaccine Adjuvants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vaccine Adjuvants covered in this report include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO and Invivogen, etc.
The global Vaccine Adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
CSL Limited
Croda
SEPPIC
Novavax
SPI Pharma
Phibro
SDA BIO
Invivogen
Tj Kaiwei
OZ Biosciences
Brenntag Biosector
MVP Laboratories
Zhuoyue
Aphios
Global Vaccine Adjuvants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vaccine Adjuvants market, Segment by Type:
Aluminum Adjuvant
Emulsions Adjuvant
Others
Global Vaccine Adjuvants market, by Application
Human Vaccine
Veterinary Vaccine
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The global Vaccine Adjuvants market size is expected to reach US$ 1569.9 million by 2029, growing at a CAGR of 9.0% from 2023 to 2029. The market is mainly driven by the significant applications of Vaccine Adjuvants in various end use industries. The expanding demands from the Human Vaccine and Veterinary Vaccine, are propelling Vaccine Adjuvants market. Aluminum Adjuvant, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Emulsions Adjuvant segment is estimated at % CAGR for the next seven-year period.
The top 5 global manufacturers of vaccine adjuvants are GSK, CSL Limited, Croda, SEPPIC, Novavax, which have a combined market share of about 55 percent. North America is the largest market, with a share about 38%, followed by Europe and Asia Pacific with the share about 27% and 22%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vaccine Adjuvants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vaccine Adjuvants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vaccine Adjuvants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vaccine Adjuvants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vaccine Adjuvants covered in this report include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO and Invivogen, etc.
The global Vaccine Adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
CSL Limited
Croda
SEPPIC
Novavax
SPI Pharma
Phibro
SDA BIO
Invivogen
Tj Kaiwei
OZ Biosciences
Brenntag Biosector
MVP Laboratories
Zhuoyue
Aphios
Global Vaccine Adjuvants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vaccine Adjuvants market, Segment by Type:
Aluminum Adjuvant
Emulsions Adjuvant
Others
Global Vaccine Adjuvants market, by Application
Human Vaccine
Veterinary Vaccine
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Vaccine Adjuvants Market Overview
1.1 Vaccine Adjuvants Product Overview
1.2 Vaccine Adjuvants Market Segment by Type
1.2.1 Aluminum Adjuvant
1.2.2 Emulsions Adjuvant
1.2.3 Others
1.3 Global Vaccine Adjuvants Market Size by Type
1.3.1 Global Vaccine Adjuvants Market Size Overview by Type (2018-2029)
1.3.2 Global Vaccine Adjuvants Historic Market Size Review by Type (2018-2023)
1.3.3 Global Vaccine Adjuvants Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vaccine Adjuvants Sales Breakdown by Type (2018-2023)
1.4.2 Europe Vaccine Adjuvants Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Vaccine Adjuvants Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Vaccine Adjuvants Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Vaccine Adjuvants Sales Breakdown by Type (2018-2023)
2 Global Vaccine Adjuvants Market Competition by Company
2.1 Global Top Players by Vaccine Adjuvants Sales (2018-2023)
2.2 Global Top Players by Vaccine Adjuvants Revenue (2018-2023)
2.3 Global Top Players by Vaccine Adjuvants Price (2018-2023)
2.4 Global Top Manufacturers Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vaccine Adjuvants Market Competitive Situation and Trends
2.5.1 Vaccine Adjuvants Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Vaccine Adjuvants Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2022)
2.7 Date of Key Manufacturers Enter into Vaccine Adjuvants Market
2.8 Key Manufacturers Vaccine Adjuvants Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vaccine Adjuvants Status and Outlook by Region
3.1 Global Vaccine Adjuvants Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Vaccine Adjuvants Historic Market Size by Region
3.2.1 Global Vaccine Adjuvants Sales in Volume by Region (2018-2023)
3.2.2 Global Vaccine Adjuvants Sales in Value by Region (2018-2023)
3.2.3 Global Vaccine Adjuvants Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Vaccine Adjuvants Forecasted Market Size by Region
3.3.1 Global Vaccine Adjuvants Sales in Volume by Region (2024-2029)
3.3.2 Global Vaccine Adjuvants Sales in Value by Region (2024-2029)
3.3.3 Global Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Vaccine Adjuvants by Application
4.1 Vaccine Adjuvants Market Segment by Application
4.1.1 Human Vaccine
4.1.2 Veterinary Vaccine
4.2 Global Vaccine Adjuvants Market Size by Application
4.2.1 Global Vaccine Adjuvants Market Size Overview by Application (2018-2029)
4.2.2 Global Vaccine Adjuvants Historic Market Size Review by Application (2018-2023)
4.2.3 Global Vaccine Adjuvants Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vaccine Adjuvants Sales Breakdown by Application (2018-2023)
4.3.2 Europe Vaccine Adjuvants Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Vaccine Adjuvants Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Vaccine Adjuvants Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Vaccine Adjuvants Sales Breakdown by Application (2018-2023)
5 North America Vaccine Adjuvants by Country
5.1 North America Vaccine Adjuvants Historic Market Size by Country
5.1.1 North America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Vaccine Adjuvants Sales in Volume by Country (2018-2023)
5.1.3 North America Vaccine Adjuvants Sales in Value by Country (2018-2023)
5.2 North America Vaccine Adjuvants Forecasted Market Size by Country
5.2.1 North America Vaccine Adjuvants Sales in Volume by Country (2024-2029)
5.2.2 North America Vaccine Adjuvants Sales in Value by Country (2024-2029)
6 Europe Vaccine Adjuvants by Country
6.1 Europe Vaccine Adjuvants Historic Market Size by Country
6.1.1 Europe Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Vaccine Adjuvants Sales in Volume by Country (2018-2023)
6.1.3 Europe Vaccine Adjuvants Sales in Value by Country (2018-2023)
6.2 Europe Vaccine Adjuvants Forecasted Market Size by Country
6.2.1 Europe Vaccine Adjuvants Sales in Volume by Country (2024-2029)
6.2.2 Europe Vaccine Adjuvants Sales in Value by Country (2024-2029)
7 Asia-Pacific Vaccine Adjuvants by Region
7.1 Asia-Pacific Vaccine Adjuvants Historic Market Size by Region
7.1.1 Asia-Pacific Vaccine Adjuvants Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Vaccine Adjuvants Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Vaccine Adjuvants Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Vaccine Adjuvants Forecasted Market Size by Region
7.2.1 Asia-Pacific Vaccine Adjuvants Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Vaccine Adjuvants Sales in Value by Region (2024-2029)
8 Latin America Vaccine Adjuvants by Country
8.1 Latin America Vaccine Adjuvants Historic Market Size by Country
8.1.1 Latin America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Vaccine Adjuvants Sales in Volume by Country (2018-2023)
8.1.3 Latin America Vaccine Adjuvants Sales in Value by Country (2018-2023)
8.2 Latin America Vaccine Adjuvants Forecasted Market Size by Country
8.2.1 Latin America Vaccine Adjuvants Sales in Volume by Country (2024-2029)
8.2.2 Latin America Vaccine Adjuvants Sales in Value by Country (2024-2029)
9 Middle East and Africa Vaccine Adjuvants by Country
9.1 Middle East and Africa Vaccine Adjuvants Historic Market Size by Country
9.1.1 Middle East and Africa Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Vaccine Adjuvants Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Vaccine Adjuvants Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Vaccine Adjuvants Forecasted Market Size by Country
9.2.1 Middle East and Africa Vaccine Adjuvants Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Vaccine Adjuvants Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Vaccine Adjuvants Products Offered
10.1.5 GSK Recent Development
10.2 CSL Limited
10.2.1 CSL Limited Company Information
10.2.2 CSL Limited Introduction and Business Overview
10.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CSL Limited Vaccine Adjuvants Products Offered
10.2.5 CSL Limited Recent Development
10.3 Croda
10.3.1 Croda Company Information
10.3.2 Croda Introduction and Business Overview
10.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Croda Vaccine Adjuvants Products Offered
10.3.5 Croda Recent Development
10.4 SEPPIC
10.4.1 SEPPIC Company Information
10.4.2 SEPPIC Introduction and Business Overview
10.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.4.4 SEPPIC Vaccine Adjuvants Products Offered
10.4.5 SEPPIC Recent Development
10.5 Novavax
10.5.1 Novavax Company Information
10.5.2 Novavax Introduction and Business Overview
10.5.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novavax Vaccine Adjuvants Products Offered
10.5.5 Novavax Recent Development
10.6 SPI Pharma
10.6.1 SPI Pharma Company Information
10.6.2 SPI Pharma Introduction and Business Overview
10.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.6.4 SPI Pharma Vaccine Adjuvants Products Offered
10.6.5 SPI Pharma Recent Development
10.7 Phibro
10.7.1 Phibro Company Information
10.7.2 Phibro Introduction and Business Overview
10.7.3 Phibro Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Phibro Vaccine Adjuvants Products Offered
10.7.5 Phibro Recent Development
10.8 SDA BIO
10.8.1 SDA BIO Company Information
10.8.2 SDA BIO Introduction and Business Overview
10.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.8.4 SDA BIO Vaccine Adjuvants Products Offered
10.8.5 SDA BIO Recent Development
10.9 Invivogen
10.9.1 Invivogen Company Information
10.9.2 Invivogen Introduction and Business Overview
10.9.3 Invivogen Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Invivogen Vaccine Adjuvants Products Offered
10.9.5 Invivogen Recent Development
10.10 Tj Kaiwei
10.10.1 Tj Kaiwei Company Information
10.10.2 Tj Kaiwei Introduction and Business Overview
10.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Tj Kaiwei Vaccine Adjuvants Products Offered
10.10.5 Tj Kaiwei Recent Development
10.11 OZ Biosciences
10.11.1 OZ Biosciences Company Information
10.11.2 OZ Biosciences Introduction and Business Overview
10.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.11.4 OZ Biosciences Vaccine Adjuvants Products Offered
10.11.5 OZ Biosciences Recent Development
10.12 Brenntag Biosector
10.12.1 Brenntag Biosector Company Information
10.12.2 Brenntag Biosector Introduction and Business Overview
10.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Brenntag Biosector Vaccine Adjuvants Products Offered
10.12.5 Brenntag Biosector Recent Development
10.13 MVP Laboratories
10.13.1 MVP Laboratories Company Information
10.13.2 MVP Laboratories Introduction and Business Overview
10.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.13.4 MVP Laboratories Vaccine Adjuvants Products Offered
10.13.5 MVP Laboratories Recent Development
10.14 Zhuoyue
10.14.1 Zhuoyue Company Information
10.14.2 Zhuoyue Introduction and Business Overview
10.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Zhuoyue Vaccine Adjuvants Products Offered
10.14.5 Zhuoyue Recent Development
10.15 Aphios
10.15.1 Aphios Company Information
10.15.2 Aphios Introduction and Business Overview
10.15.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Aphios Vaccine Adjuvants Products Offered
10.15.5 Aphios Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vaccine Adjuvants Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vaccine Adjuvants Industrial Chain Analysis
11.4 Vaccine Adjuvants Market Dynamics
11.4.1 Vaccine Adjuvants Industry Trends
11.4.2 Vaccine Adjuvants Market Drivers
11.4.3 Vaccine Adjuvants Market Challenges
11.4.4 Vaccine Adjuvants Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vaccine Adjuvants Distributors
12.3 Vaccine Adjuvants Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
